Description

LuciRevu 110mg Tablet (Revumenib) Uses, Side Effects, Dosage & Price in Pakistan

LuciRevu 110mg Tablet (Revumenib) is a prescription cancer medicine belonging to a class of medicines called menin inhibitors. Revumenib is used for certain types of relapsed or refractory acute leukemia, including acute leukemia with a KMT2A translocation and acute myeloid leukemia (AML) with a susceptible NPM1 mutation, depending on the patient’s age, disease status, and treatment history.

If you are searching for LuciRevu 110mg Tablet (Revumenib) uses, dosage, side effects, or price in Pakistan, this guide provides useful information in simple wording. LuciRevu should only be used under the supervision of a qualified healthcare professional.

LuciRevu 110mg Tablet (Revumenib) Uses

LuciRevu may be prescribed for certain patients with:

• Relapsed or refractory acute leukemia with a KMT2A translocation.
• Relapsed or refractory acute myeloid leukemia (AML) with a susceptible NPM1 mutation when there are no satisfactory alternative treatment options.
• Disease that has returned after previous treatment or has not responded adequately to earlier therapies.

Current prescribing information allows use in adults and pediatric patients 1 year of age and older for the approved indications. Patient selection requires appropriate molecular testing for the relevant genetic abnormality.

How LuciRevu Works

LuciRevu contains revumenib, a menin inhibitor. Menin is involved in molecular processes that can contribute to the growth and survival of certain leukemia cells.

By blocking menin-related activity, revumenib can help interfere with abnormal leukemia-driving pathways. This targeted approach is particularly relevant to acute leukemias involving KMT2A translocations or susceptible NPM1 mutations.

LuciRevu 110mg Tablet (Revumenib) Dosage

The dose of revumenib is not determined simply by the 110mg tablet strength. The recommended dosage can vary according to factors such as:

• Patient body weight
• Age
• The specific leukemia being treated
• Use of strong CYP3A4 inhibitors
• Treatment response
• Side effects and laboratory results

Revumenib is generally administered twice daily, approximately 12 hours apart. The exact number and strength of tablets required should be determined by the treating oncologist.

Do not increase, reduce, or change your LuciRevu dose without medical advice.

How to Take LuciRevu

Take LuciRevu exactly as prescribed by your doctor.

• Take it orally twice a day at approximately the same times.
• It can be taken on an empty stomach or with a low-fat meal.
• Swallow tablets whole with water unless your healthcare professional provides instructions for preparation in water.
• Do not cut or chew the tablets.
• If you vomit after taking a dose, do not take another dose. Continue with your normal dosing schedule.
• If you miss a dose, follow your prescribed instructions and do not take two doses within 12 hours.

LuciRevu 110mg Tablet Side Effects

Some people may experience side effects during treatment with revumenib. Possible side effects include:

• Nausea
• Vomiting
• Constipation
• Diarrhea
• Reduced appetite
• Tiredness
• Muscle, joint, or bone pain
• Swelling of the arms or legs
• Changes in blood tests
• Electrolyte abnormalities

Side effects can vary from patient to patient. Your doctor may adjust or temporarily stop treatment if significant adverse effects develop.

Serious Side Effects and Warnings

LuciRevu has important safety warnings. Two major concerns associated with revumenib are differentiation syndrome and QTc interval prolongation, which can lead to serious heart rhythm problems.

Differentiation Syndrome

Differentiation syndrome can be serious or life-threatening. Symptoms may include:

• Fever
• Cough
• Shortness of breath
• Sudden weight gain
• Swelling
• Reduced urination
• Dizziness or lightheadedness
• Severe headache
• Confusion

Differentiation syndrome may occur from a few days to several weeks after treatment begins. Contact your doctor immediately if these symptoms develop.

QTc Prolongation and Heart Rhythm Problems

Revumenib can prolong the QT interval and may cause a potentially dangerous heart rhythm called Torsades de Pointes. Low potassium or magnesium levels should be corrected before and during treatment.

Current prescribing information states that treatment should not be initiated when QTcF is greater than 450 milliseconds. ECG and laboratory monitoring may be required during treatment.

Precautions Before Using LuciRevu

Before starting LuciRevu 110mg Tablet, tell your doctor if you have:

• A history of abnormal heart rhythm
• Electrolyte problems
• Liver or other significant medical conditions
• Any allergies
• A history of serious drug reactions
• Any upcoming surgery or dental procedure

Tell your doctor about all medicines, vitamins, supplements, and herbal products you take. Revumenib can interact with medicines that affect CYP3A4, and QT-prolonging medicines may require special consideration.

Avoid starting medicines or supplements such as St. John’s Wort without discussing them with your healthcare provider.

Pregnancy and Breastfeeding

Revumenib may cause fetal harm. Women who can become pregnant should discuss effective contraception with their healthcare provider before and during treatment.

Breastfeeding is not recommended while receiving revumenib.

LuciRevu 110mg Price in Pakistan

The LuciRevu 110mg Tablet (Revumenib) price in Pakistan may vary depending on availability, supplier, manufacturer, packaging, and market conditions.

For the latest LuciRevu 110mg price in Pakistan, patients and healthcare providers can contact Impo Medic for current availability and product information.

How to Buy LuciRevu 110mg Tablet (Revumenib) in Pakistan

LuciRevu 110mg Tablet is a prescription cancer medicine and should be used only according to the treatment plan provided by an oncologist.

If you want to buy LuciRevu 110mg Tablet in Pakistan, you can contact Impo Medic to check current product availability and ordering information.

Before purchasing revumenib, make sure you have the appropriate prescription and medical guidance. Do not self-medicate with this medicine because treatment requires appropriate genetic testing, monitoring, and management of potential serious adverse reactions.

Why Choose Impo Medic for LuciRevu 110mg Tablet?

Impo Medic provides clear and useful information about prescription medicines, including their uses, dosage, side effects, precautions, and availability in Pakistan.

For LuciRevu 110mg Tablet (Revumenib), our goal is to make important medicine information easier to understand while encouraging patients to follow the advice of their oncologist. Impo Medic can also help users check product availability and obtain relevant information before ordering.

Frequently Asked Questions About LuciRevu 110mg

What is LuciRevu 110mg Tablet used for?

LuciRevu contains revumenib and is used for certain relapsed or refractory acute leukemias involving a KMT2A translocation or, in eligible patients, an NPM1 mutation.

What is Revumenib?

Revumenib is a targeted menin inhibitor used to treat certain genetically defined acute leukemias.

How often is LuciRevu taken?

Revumenib is generally taken twice daily, approximately 12 hours apart. The exact dose depends on factors such as body weight, age, indication, and drug interactions.

Can LuciRevu 110mg be taken with food?

Revumenib may be taken without food or with a low-fat meal. Follow your doctor’s specific instructions regarding food and timing.

What are the serious side effects of LuciRevu?

Important serious risks include differentiation syndrome and QTc prolongation/Torsades de Pointes. Symptoms such as breathing difficulty, sudden swelling, faintness, severe dizziness, or an abnormal heartbeat require prompt medical attention.

Can LuciRevu be used during pregnancy?

Revumenib can cause fetal harm. Pregnancy precautions and effective contraception should be discussed with the treating healthcare professional.

Where can I buy LuciRevu 110mg Tablet in Pakistan?

For information about LuciRevu 110mg Tablet (Revumenib) in Pakistan, including availability and current product details, contact Impo Medic.

Can I change my LuciRevu dose myself?

No. Revumenib dosing can depend on body weight, drug interactions, disease type, and side effects. Any dose change should be made by the treating oncologist.